Recombinant Human GNPTG Protein，His

Gnptg, or N-acetylglucosamine-1-phosphate transferase gamma subunit, plays a crucial role in lysosomal enzyme biogenesis by facilitating the phosphorylation of lysosomal enzymes, which is essential for their proper sorting and function. Mutations in the GNPTG gene have been linked to several lysosomal storage disorders, including mucolipidosis II and III, which are characterized by the accumulation of undegraded substrates in the lysosomes, leading to severe clinical manifestations such as cognitive impairment, organ dysfunction, and skeletal abnormalities. Understanding the molecular mechanisms underlying GNPTG function and its encoded protein is vital for developing potential therapeutic strategies for these genetic disorders. Additionally, recombinant GNPTG protein serves as a valuable tool for studying enzyme-enzyme interactions, understanding the phosphorylation process of lysosomal enzymes, and screening small-molecule inhibitors that may assist in the treatment of related disorders. Recent advances in protein expression and purification techniques have allowed for detailed structural and functional analyses of GNPTG, paving the way for potential gene therapy approaches and molecular interventions aimed at ameliorating the effects of GNPTG-related disease. As research in this area continues to evolve, the insights gained could one day lead to more effective treatments and improved quality of life for patients affected by lysosomal storage disorders caused by GNPTG mutations.